SCHEMBL1105653

SCHEMBL1105653

CNC(=O)CON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18107025 0.97
SCHEMBL13411713 0.77 LMNA (0.42)
SCHEMBL11392050 0.76
SCHEMBL103430 0.74
SCHEMBL829201 0.74
SCHEMBL16158612 0.74 LMNA (0.38)
Hydrochloric Acid SCHEMBL11397553 0.74
SCHEMBL25872819 0.74
SCHEMBL1562425 0.74
SCHEMBL9921632 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1780197-B9 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS CHUGAI PHARMACEUTICAL CO LTD (JP) 2011-04-06 EP claimed
EP-1780197-B1 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS CHUGAI PHARMACEUTICAL CO LTD (JP) 2010-10-20 EP claimed
US-7745663-B2 5-Substituted-2-phenylamino benzamides as MEK inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-06-29 US claimed
US-20090233915-A1 5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-09-17 US claimed
EP-0765304-B2 METHOD OF PREPARING ALPHA-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BAYER CROPSCIENCE AG (DE) 2007-08-22 EP claimed
EP-1780197-A1 5-SUBSTITUTED-2-PHENYLAMINO-BENZAMIDE AS MEK INHIBITOR CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-05-02 EP claimed
EP-0765304-B1 METHOD OF PREPARING ALPHA-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BASF AG (DE) 1999-08-11 EP claimed
US-5856560-A REACTING ACYL CYANIDE BENZENE COMPOUND WITH AN ALCOHOL; THEN AN HYDROXYLAMINE; METHYLATION BASF AKTIENGESELLSCHAFT (DE) 1999-01-05 US claimed
US-20230302150-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2023-09-28 US disclosed
US-11311636-B2 Radiotracer compositions and methods GE HEALTHCARE LIMITED (GB) 2022-04-26 US disclosed
US-20210330824-A1 PURIFICATION METHOD AND COMPOSITIONS GE HEALTHCARE LTD (GB) 2021-10-28 US disclosed
EP-3277685-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2021-01-13 EP disclosed
EP-3721902-A1 TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF The Scripps Research Institute (US) 2020-10-14 EP disclosed
US-10570131-B2 Heterocyclic compounds and their use in preventing or treating bacterial infections MUTABILIS (FR) 2020-02-25 US disclosed
WO-2005097129-A2 6-AZAINDOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-10-20 WO disclosed
EP-0765304-B1 METHOD OF PREPARING ALPHA-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BASF AG (DE) 1999-08-11 EP disclosed
US-5856560-A REACTING ACYL CYANIDE BENZENE COMPOUND WITH AN ALCOHOL; THEN AN HYDROXYLAMINE; METHYLATION BASF AKTIENGESELLSCHAFT (DE) 1999-01-05 US disclosed
US-5856560-A REACTING ACYL CYANIDE BENZENE COMPOUND WITH AN ALCOHOL; THEN AN HYDROXYLAMINE; METHYLATION BASF AKTIENGESELLSCHAFT (DE) 1999-01-05 US disclosed
EP-0765304-A1 METHOD OF PREPARING ALPHA-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BASF AKTIENGESELLSCHAFT (DE) 1997-04-02 EP disclosed
WO-1995034526-A1 METHOD OF PREPARING α-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BASF AKTIENGESELLSCHAFT (DE) 1995-12-21 WO disclosed